Chemoinformaics analysis of Trans-resversatrol
| Molecular Weight | 228.247 | nRot | 2 |
| Heavy Atom Molecular Weight | 216.151 | nRig | 13 |
| Exact Molecular Weight | 228.079 | nRing | 2 |
| Solubility: LogS | -2.273 | nHRing | 0 |
| Solubility: LogP | 2.994 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 33.7875 |
| nHD | 3 | BPOL | 12.0385 |
| QED | 0.692 |
| Synth | 2.112 |
| Natural Product Likeliness | 0.754 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.455 |
| Pgp-sub | 0.102 |
| HIA | 0.012 |
| CACO-2 | -4.916 |
| MDCK | 0.0000143 |
| BBB | 0.032 |
| PPB | 0.972684 |
| VDSS | 0.822 |
| FU | 0.0262024 |
| CYP1A2-inh | 0.976 |
| CYP1A2-sub | 0.11 |
| CYP2c19-inh | 0.229 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.356 |
| CYP2c9-sub | 0.957 |
| CYP2d6-inh | 0.629 |
| CYP2d6-sub | 0.915 |
| CYP3a4-inh | 0.943 |
| CYP3a4-sub | 0.163 |
| CL | 15.661 |
| T12 | 0.924 |
| hERG | 0.109 |
| Ames | 0.076 |
| ROA | 0.451 |
| SkinSen | 0.959 |
| Carcinogencity | 0.287 |
| EI | 0.97 |
| Respiratory | 0.405 |
| NR-Aromatase | 0.413 |
| Antiviral | No |
| Prediction | 0.731179 |